COVID-19 Updates
Conference Coverage
Does atopic dermatitis pose an increased risk of acquiring COVID-19?
From the Journals
COVID-19 vaccinations in people with HIV reflect general rates despite higher mortality risk, study says
Latest News
COVID booster protection may wane in about 10 weeks, new data show
“It will be a few weeks before effectiveness against severe disease with Omicron can be estimated.”
From the Journals
Remdesivir may keep unvaccinated out of the hospital: Study
News
FDA OKs emergency use of Merck pill for COVID-19
Similar to FDA authorization of another antiviral pill regimen granted to Pfizer, molnupiravir should be taken early in the course of COVID-19...
From the Journals
New studies suggest Omicron infections are less severe than Delta ones
News from the FDA/CDC
FDA authorizes Pfizer antiviral pill for COVID-19
Latest News
Pandemic poses short- and long-term risks to babies, especially boys
For fetuses exposed to COVID, the greatest danger is usually not the coronavirus itself, but the mother’s immune system.
From the Journals
GI symptoms in kids with COVID may predict severe outcomes
From the Journals
Convalescent plasma cuts COVID-19 hospitalizations in half: Study
From the Journals
Bamlanivimab’s effects in COVID-19 depend on antibodies
Bamlanivimab was more effective in hospitalized COVID-19 patients without endogenous neutralizing antibodies.